Genomic profiling of Escherichia coli isolates from bacteraemia patients: a 3-year cohort study of isolates collected at a Sydney teaching hospital. by Hastak P et al.
1
Genomic profiling of Escherichia coli isolates from bacteraemia 
patients: a 3- year cohort study of isolates collected at a Sydney 
teaching hospital
Priyanka Hastak1,2, Max L. Cummins1, Thomas Gottlieb3,4, Elaine Cheong3, John Merlino3,4, Garry S. A. Myers1, Steven 
P. Djordjevic1,2 and Piklu Roy Chowdhury1,2,*
RESEARCH ARTICLE
Hastak et al., Microbial Genomics 2020;6
DOI 10.1099/mgen.0.000371
Received 14 September 2019; Accepted 03 April 2020; Published 06 May 2020
Author affiliations: 1The ithree institute, University of Technology Sydney, City Campus, Ultimo, NSW 2007, Australia; 2Australian Centre for Genomic 
Epidemiological Microbiology, University of Technology Sydney, PO Box 123, Broadway, NSW 2007, Australia; 3Department of Microbiology and Infectious 
Diseases, Concord Hospital and NSW Health Pathology, Hospital Road, Concord 2139, NSW, Australia; 4Faculty of Medicine, University of Sydney, NSW 
Australia.
*Correspondence: Piklu Roy Chowdhury,  piklu. bhattacharya@ uts. edu. au
Keywords: Escherichia coli; bacteraemia; blood stream infections; ESBL; fluoroquinolone resistance; multidrug resistance; class 1 integrons; IncF 
plasmids; IS26; bla
CTX- M
; E. coliST8196; qnrB4.
Abbreviations: AGAR, Australian Group for Antimicrobial Resistance; AMR, antimicrobial resistance; BSI, blood stream infections; CO, community 
onset; CRL, complex resistance loci; EIEC, Entero- invasive Escherichia coli; ESBL, extended spectrum beta- lactamase; ETEC, Entero- toxigenic 
Escherichia coli; ExPEC, Extra- intestinal pathogenic Escherichia coli; GNSOP, gram- negative bacteraemia surveillance programme; HO, hospital onset; 
MDR, multidrug resistance/resistant; ST, sequence type; UPEC, Uropathogenic Escherichia coli; UTI, urinary tract infections; VAG, virulence associated 
genes; WGS, whole genome sequencing.
GenBank Project ID PRJNA480723.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary data files. Six supplementary 
tables and one supplementary figure is available with the online version of this article.
000371 © 2020 The Authors
This is an open- access article distributed under the terms of the Creative Commons Attribution NonCommercial License.
Abstract
This study sought to assess the genetic variability of Escherichia coli isolated from bloodstream infections (BSIs) present-
ing at Concord Hospital, Sydney during 2013–2016. Whole- genome sequencing was used to characterize 81 E. coli isolates 
sourced from community- onset (CO) and hospital- onset (HO) BSIs. The cohort comprised 64 CO and 17 HO isolates, including 35 
multidrug- resistant (MDR) isolates exhibiting phenotypic resistance to three or more antibiotic classes. Phylogenetic analysis 
identified two major ancestral clades. One was genetically diverse with 25 isolates distributed in 16 different sequence types 
(STs) representing phylogroups A, B1, B2, C and F, while the other comprised phylogroup B2 isolates in subclades representing 
the ST131, ST73 and ST95 lineages. Forty- seven isolates contained a class 1 integron, of which 14 carried bla
CTX -M-
gene. Isolates 
with a class 1 integron carried more antibiotic resistance genes than isolates without an integron and, in most instances, resist-
ance genes were localized within complex resistance loci (CRL). Resistance to fluoroquinolones could be attributed to point 
mutations in chromosomal parC and gyrB genes and, in addition, two isolates carried a plasmid- associated qnrB4 gene. Co- 
resistance to fluoroquinolone and broad- spectrum beta- lactam antibiotics was associated with ST131 (HO and CO), ST38 (HO), 
ST393 (CO), ST2003 (CO) and ST8196 (CO and HO), a novel ST identified in this study. Notably, 10/81 (12.3 %) isolates with ST95 
(5 isolates), ST131 (2 isolates), ST88 (2 isolates) and a ST540 likely carry IncFII–IncFIB plasmid replicons with a full spectrum of 
virulence genes consistent with the carriage of ColV- like plasmids. Our data indicate that IncF plasmids play an important role 
in shaping virulence and resistance gene carriage in BSI E. coli in Australia.
DATA SummARy
The genome sequences of the isolates included in this paper 
have been made accessible via GenBank, under project ID 
PRJNA480723. A list of individual accession numbers for 
the assembled genomes is provided in File S1. The genome 
sequence of the novel E. coli ST8196 was registered in 
Enterobase and is searchable using the sequence type numbers 
and Uber strain IDs ESC_IA6781AA and ESC_IA7243AA. 
All online databases were accessed through portals on the 
Centre Of Genomic Epidemiology website (http://www. 
genomicepidemiology. org/).
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InTRoDuCTIon
Escherichia coli is a major cause of bloodstream infections 
(BSIs), dominating the list of Gram- negative pathogens 
associated with bacteraemia and sepsis globally [1]. In 2017, 
treatment costs for patients with sepsis in Australian intensive 
care units were estimated to be at least USD $846 million [2]. 
In that year, 55.2 % of Gram- negative BSIs were caused by 
E. coli, of which 83.6 % were from community and 16.4 % 
from hospitalized patients [3]. Nationwide, the incidence of 
multidrug resistance associated with E. coli BSIs increased 
from 11.8 % in 2013 [4] to 21.9 % in 2017 [3]. This was also 
accompanied by an increase in the frequency of the isolation 
of multidrug- resistant (MDR) E. coli displaying resistance to 
fluoroquinolones and extended- spectrum beta- lactams [3].
Extra- intestinal pathogenic E. coli (ExPEC) are usually associ-
ated with BSIs and sepsis. ExPEC causing human infections 
are often characterized by the presence of P and S fimbriae 
that facilitate human cell attachment, toxins and cytone-
crotic factors that enable invasion and subsequent damage, 
iron acquisition systems, serum resistance proteins [5, 6], 
capsular polysaccharides and lipopolysaccharides (LPS) that 
support survival in the host. E. coli BSIs predominantly have a 
community onset, with urinary tract infections (UTIs) being 
the most frequently reported principal clinical manifestation 
[3, 7]. Uropathogenic E. coli (UPEC) are a subgroup of ExPEC 
that are adept at colonizing the urethra and ascending into the 
urinary bladder causing cystitis. A 3- month sentinel surveil-
lance of E. coli bacteraemia cases in the UK in 2012/2013, 
which included 35 hospitals, linked 51.2 % of the cases to UTI 
[8]. The first- line drugs used to treat UTI in Australia include 
trimethoprim, amoxicillin/clavulanate and cephalexin. Genes 
conferring resistance to trimethoprim are often present as 
gene cassettes on class 1 integrons, a globally disseminated 
mobile genetic element best known for its role in the rapid 
evolution of MDR pathogens [9–11]. Within enterobacterial 
genomes, class 1 integrons are frequently detected in regions 
where resistance genes cluster together, forming resistance 
loci. Hence they serve as a reliable proxy for the identification 
of multiple drug resistant genomes within cohorts of bacteria 
collected from clinical settings [12], food animals [13–15] 
and the environment [16]. Increasing resistance to aminogly-
cosides, extended- spectrum beta- lactams, fluoroquinolones 
and trimethoprim is a major threat to the treatment of E. coli 
infections, including BSIs [17–21]. Plasmids play a major role 
in driving the evolution of pathogens resistant to these anti-
biotics through the rapid dispersal of virulence and antibiotic 
resistance genes [22, 23] within enterobacterales. Examples 
of plasmid- mediated rapid pathogen evolution include the 
establishment of enterotoxigenic E. coli (ETEC) [24, 25] and 
enteroinvasive E. coli (EIEC) [26] pathotypes, which cause 
watery diarrhoea and bacillary (often bloody) dysentery, 
respectively.
Globally, the most predominant ExPEC sequence types (STs) 
associated with UTI include ST69, ST73, ST95 and ST131 
[27, 28]. Specifically, the ST131 lineage is recognized as a 
significant aetiological agent of UTI, pyelonephritis and 
urosepsis [29, 30]. The wide distribution of ST131, together 
with relatively higher numbers of drug resistance and viru-
lence genes, has made it the most well- studied ExPEC lineage 
[31, 32]. The emergence of MDR BSIs is often associated 
with isolates that have acquired genes encoding extended- 
spectrum beta- lactamases (ESBLs), particularly blaCTX- M. 
There are over 100 allelic variants of blaCTX- M [33–35] and 
different alleles predominate in E. coli, depending on several 
factors, including geographical location [36]. BSIs in Argen-
tina, South Africa, Turkey, Belgium, China, Taiwan and 
Australia are typically caused by E. coli that carry blaCTX- M-2, 
blaCTX- M-3 and blaCTX- M-15 [37–39].
Surveillance of antibiotic- resistant pathogens has provided 
important insights into the distribution and prevalence of 
antibiotic resistance in Australia [40], and has highlighted 
rising rates of ESBL- producing and fluoroquinolone- resistant 
MDR E. coli causing BSIs [3, 7, 41]. Whole- genome sequencing 
(WGS) of pathogens causing BSIs facilitates the identification 
of AMR gene carriage and virulence- associated genes (VAGs) 
and links their carriage with ST, phylogroup and e- serotype. It 
also provides insights into the genetic context of AMR genes 
and VAGs and sheds light on the associations of AMR genes 
with mobile genetic elements. In addition to these attributes, 
WGS enables effective microbial source tracking.
In this report, we present an analysis of E. coli whole- genome 
sequences collected from patients with bacteraemia (BSI) 
attending Concord Hospital, Sydney between January 2013 
and March 2016. We investigate the genetic diversity of E. coli 
that cause BSIs, describe the genetic context of the resistance 
Impact Statement
We report on the genomic surveillance of 81 Escherichia 
coli isolates collected from patients treated for blood-
stream infections (BSIs) at the Concord Repatriation 
Hospital in Sydney, Australia between January 2013 and 
March 2016. Our data describe the population dynamics 
and highlight a segregation between virulent and drug- 
resistant clonal lineages in the cohort, akin to trends 
reported recently in a study on a cohort of more than 
1500 invasive E. coli isolates collected over 11 years in 
the UK. Our study identifies a novel sequence type of 
E. coli, ST8196, within the ST131 clonal cluster, and the 
possible role of large ColV- like IncF plasmids in shaping 
the virulence and resistance profiles of isolates in this 
cohort. We additionally present compelling evidence on 
the active role played by IS26 in the ongoing evolution 
and clustering of antimicrobial resistance genes in E. coli 
from both community- onset (CO) and hospital- onset (HO) 
BSIs. Collectively, our results highlight why surveillance 
protocols that target the mobilome are needed to better 
understand features that distinguish CO and HO infec-
tions.
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gene carried by these isolates and identify genetic elements 
that disseminate AMR genes and VAGs.
mETHoDS
E. coli collection and growth conditions
Between January 2013 and March 2016, 406 E. coli isolates were 
collected by the Microbiology Department at Concord Repa-
triation Hospital in Sydney and stored as part of the Australian 
Group for Antimicrobial Resistance (AGAR) Gram- negative 
bacteraemia surveillance programme (GNSOP). We selected 
81 isolates representative of the spectrum of phenotypic anti-
biotic resistance profiles for whole- genome sequence analysis. 
Clinical metadata, including collection year, likely source of 
infection and phenotypic resistance profile, are presented 
in File S1 (available in the online version of this article). A 
48 h post- admission cut- off for sample collection was used to 
distinguish community- onset (CO) and hospital- onset (HO) 
infections. Isolates were sub- cultured and grown at 37 °C for 
18 h on lysogeny broth (LB) and the pellets were used for 
purification of DNA.
Antimicrobial resistance phenotyping
Antibiotic susceptibility profiles were generated using the 
Advanced Expert System (AES) software designed for VITEK 
2 (BioMerieux). Breakpoints were interpreted using Euro-
pean Committee on Antimicrobial Susceptibility Testing 
(EUCAST) guidelines [42] at the Microbiology Laboratory, 
Concord Hospital. The panel of antibiotics tested comprised 
ampicillin (AMP), amoxicillin (AMC), ciprofloxacin 
(CIP), cefazolin (CFZ), cefotaxime (CTX), ceftriaxone 
(CRO), ceftazidime (CAZ), cefoxitin (FOX), trimethoprim 
(TRI), gentamicin (GEN), tobramycin (TOB), norfloxacin 
(NOR), ticarcillin/clavulanic acid (TCC), piperacillin/
tazobactam(TZP) trimethoprim/sulfamethoxazole (SXT) and 
amikacin (AMK). Synergy tests were used to phenotypically 
identify isolates producing ESBL enzymes (File S1). For the 
purposes of this study, multi- drug resistance was defined as 
resistance to ≥three classes of antibiotics [43].
Genomic DnA extraction and sequencing library 
preparation
Genomic DNA was extracted from 2 ml of overnight cultures 
using the ISOLATE II Genomic DNA kit (Bioline, Australia), 
following the manufacturer’s protocol, and quantified using 
the Qubit fluorimeter and dsDNA HS Assay kit (Thermo 
Fisher Scientific, Australia). WGS libraries were prepared 
from 2 ng of gDNA using the Illumina Nextera XT DNA kit 
following previously published protocols [44].
WGS and assembly
WGS was performed using the Illumina HiSeq 2500 v4 and 
the rapid PE150 mode (Illumina, San Diego, CA, USA). 
Based on FastQC reports, mean read lengths between 120 
nt and 125 nt (with Phred scores ≥30) were used for genome 
assembly using the A5- miSeq pipeline (version 20150522) 
[45]. The number of scaffolds per genome varied from 30 
to 200, with median sequence coverage ranging between 
23× and 54× (File S2). Preliminary genome annotations 
were performed on RASTtk (http:// rast. nmpdr. org/) [46] 
and regions of interest were manually curated using online 
versions of blastn and iterative blastp searches. The 
assembled genome sequences are available in GenBank 
under project ID PRJNA480723. The BioSample accession 
numbers are listed in File S2.
Gene identification and multi-locus sequence type 
(mLST) analysis
The Antimicrobial Resistance Identification By Assembly 
(ARIBA) pipeline (v2.6.1) [47] was used to rapidly detect 
the presence of the class 1 integrase gene intI1, antimicro-
bial resistance genes (ARGs), virulence- associated genes 
(VAGs), specific insertion elements, O- and H- antigen genes 
and Clermont phylogroups. The output was filtered strictly 
for hits that had 100 % query coverage and ≥99 % sequence 
identity. Genomes that did not return a match based on our 
stringent parameters were individually assessed either by 
blastn analysis (intI1 gene) or via portals on the Centre of 
Genomic Epidemiology website using assembled sequences 
(http://www. genomicepidemiology. org/) of respective 
genomes. Raw Illumina reads were mapped to pCERC-4 
(accession no. KU578032) and pSDJ2009- 52F (accession 
no. MH195200.1) to assess presence of genetic markers of 
the IncFII–IncFIB–ColV hybrid plasmids using published 
protocols [13]. The read mapping exercise was comple-
mented with blast analysis of pCERC-4 against assem-
bled genome sequences to present summary of findings 
presented in the manuscript. Genomes exhibiting ≥95 % 
sequence identity over 100 % query sequence of (i) a full 
complement of the colicin- V operon, (ii) virulence genes 
on pCERC-4 and (iii) linkage (defined by presence on the 
same genomic scaffold) of at least one of the repA genes 
on pCERC-4 with two or more Col- V- specific virulence 
gene/s, exhibiting specified identity cutoffs were identified 
as candidate genomes that likely host a Col- V plasmid. 
MLST analysis was performed using the Achtman E. coli 
MLST scheme on the PubMLST database (http:// pubmlst. 
org/) and the plasmid replicons were identified using the 
Plasmid Finder database (https:// cge. cbs. dtu. dk/ services/ 
PlasmidFinder/) [48].
Phylogenetic analysis
Reference gene- based maximum- likelihood phylogeny 
analysis (using 37 prokaryotic marker genes) was 
performed using Phylosift (v1.0.1) [49]. FastTree version 
2.1.8 .c was used to construct a phylogenetic tree (http://
www. microbesonline. org/ fasttree/ FastTree- 2. 1. 8. c) and 
visualized using FigTree v1.4.2 [44]. The reference genomes 
used in the initial analysis were E. coli K12 (U00096.2) and 
E. coli EC958 (NZ_HG941718.1) and Klebsiella pneumoniae 
subsp. pneumoniae MGH78578 (CP000647.1) was used as 
an outlier. To increase the resolution of the branches, the 
outer layer was removed from the final tree presented in this 
paper (Figs 1 and 2). The tree figures were edited using iTol 
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Fig. 1. A mid- point rooted maximum- likelihood phylogenetic tree of isolates included in the cohort. Panels on the right- hand side indicate 
their year of isolation, in silico phylogrouping, O- antigen and H- antigen profiles. The tree includes two reference genomes, E. coli K12 and 
EC958. The year of isolation was not available for the two reference genomes and hence is labelled as NA NAin the metadata column. 
The strain labels coloured in blue indicate isolates from hospital- acquired infections. MDR strains are marked with an asterisk (*), ESBL 
producers are marked with a dollar sign ($) and fluoroquinolone- resistant isolates are marked with a hash (#).
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Fig. 2. Diagrammatic representation of class 1 integron- associated complex resistance loci identified in this study. The terminal IS26s 
(red arrows) are mostly fragmented, and their relative orientation depicted in the diagram is based on analysis of the partial IS26 
sequence. Figure not to scale.
online tree management software (https:// itol. embl. de/) 
and virulence heatmaps were created using the Burrows–
Wheeler Aligner (BWA) 0.7.17, samtools 0.1.18 and ggplot2 
in the R package [50] . The scripts and commands utilized 
for the heatmap are available on Github (https:// github. 
com/ maxlcummins/ APEC- MGEN- 2018).
RESuLTS
Isolate metadata
Clinical metadata corresponding to the 81 deidentified bacte-
rial samples (File. S1) indicated that 37 isolates (45.5 %) were 
associated with UTIs and most of these (64/81; 79 %) were 
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recovered from CO infections. The cohort included 35 MDR 
isolates of which 13 exhibited co- resistance to fluoroqui-
nolones and ESBLs. Assembly statistics (File S2) indicated 
≥23× coverage.
Phylogeny and ST distribution
Thirty different E. coli STs (File. S1) were identified within 
this BSI cohort. Phylogenetic analysis revealed two major 
ancestral clusters (Fig. 1). The upper major clade contained 
25 isolates distributed in 16 STs (Fig. 1). Fifty- six isolates 
that clustered in the lower major clade comprised 15 STs, 
including globally recognized E. coli clonal groups ST73 (17 
isolates), ST131 (15 isolates), ST95 (8 isolates) and ST127 (4 
isolates). Isolates in the upper major clade of the phylogenetic 
tree contained representive of Clermont phylogroups B2, D, 
F, A and B1, while all isolates in the lower major clade of the 
phylogenetic tree, irrespective of ST type and O and H surface 
antigens typed as phylogroup B2, known to be associated with 
pathogenic strains. The relative abundance of CO infections 
within clinically significant STs were ST73 (16 of 17), ST131 
(10 of 15), ST95 (7 of 8) and ST69 (2 of 5) was noteworthy. 
The resistance genes, class 1 integron- associated genes and 
plasmid replicon types in the entire cohort are presented in 
Table 1.
E. coli STs ST8196 (two isolates) and ST8197 (one isolate) are 
novel and were registered in Enterobase (https:// enterobase. 
warwick. ac. uk/ species/ index/ ecoli). ST8196 is closely related 
to the ST131- O25:H4 sub- clade (Fig. 1) and is a new member 
of the ST131 clonal complex. The ST8196 isolates, EC233 and 
EC234, were MDR and were isolated from blood specimens 
of separate patients within a 24 h period. EC233 was from a 
patient with CO UTI, while EC234 was from a patient with a 
hospital- onset infection. Both isolates displayed phenotypic 
resistance to fluoroquinolones and produced ESBLs. The 
ST8197 isolate EC128 is closely related to members of the 
ST144 subclade (Fig. 1), a ST that shares the closest common 
ancestor with ST95. Isolate EC128_ST8197 was resistant to 
ampicillin and trimethoprim/sulfamethoxazole and suscep-
tible to all other antibiotics tested.
Most (21; 60 %) of the 35 MDR isolates clustered within the 
ST131 (13 isolates) and ST73 (8 isolates) subclades (Fig. 1). 
Genes responsible for ESBL production and fluoroquinolone 
resistance phenotypes in the MDR -cohort were not restricted 
to isolates in the ST131 sub- clade, but also present in ST38 
(HO isolate EC36), ST393 (CO isolate EC66), ST2003 (CO 
isolate EC137) and ST8196 (EC233 from CO and EC234 from 
HO) representatives.
Genetic context of class 1 integrons and resistance 
genes
Of the 81 isolates, 47 (58 %) carried a class 1 integron 
(Table  1). Aminoglycoside adenyl transferase genes 
aadA1, aadA2 (streptomycin resistance) and aadA5 (spec-
tinomycin resistance), dihydrofolate reductase gene alleles 
dfrA1, dfrA7, dfrA14, dfrA14 and dfrA17, encoding resist-
ance to trimethoprim, cmlA1 (encoding chloramphenicol 
resistance) and blaOXA-1 (encoding host- specific low- level 
resistance to ESBL antibiotics), were most frequently present 
in cassette arrays associated with class 1 integrons in this 
collection (Table 1). The IncX4 replicon was identified in 
five isolates. Sixteen isolates harboured the aadA5–dfrA17 
[Fig. 2a (14), e(2)] cassette array, while others comprised 
different combinations of the gene cassettes listed above and 
in Table 1. Genomic scaffolds containing class 1 integrons 
often carried other clustered resistance genes (Fig. 2) inter-
spersed with different insertion elements. Integrons bearing 
the aadA5–dfrA17 cassette array were almost always linked 
to a macrolide resistance module encoded by mphA and 
mphR genes beyond the 3′-CS (conserved segment) of the 
class 1 integron, forming a complex resistance locus (CRL) 
(Fig. 2a). IS26 sequences flanked the majority of scaffolds 
carrying a class 1 integron (Fig. 2). Most isolates (64/81; 
79 %), irrespective of the resistance gene carriage, carried 
multiple copies of IS26 (File S1), which likely contributed 
to fragmentations in genome assemblies.
The genes encoding resistance to ESBL were restricted to 
three allelic variants of blaCTX- M: blaCTX- M-14, blaCTX- M-15 and 
blaCTX- M-27. In most instances, blaCTX- M-15 genes were associated 
with ISEcp1 (File S1). In EC137_ST2003 and EC398_ST4702, 
blaCTX- M-14 was associated with ISEcp1b. Isolate EC345_ST10 
had a class 1 integron with a blaOXA-1 gene cassette (Fig. 2i), 
but with no detectable enzymatic activity. Fluoroquinolone 
resistance in most isolates was attributed to mutations in gyrB 
and parC chromosomal genes except in isolates EC46_ST131, 
EC44_ST131 and EC137_ST2003, which additionally had 
acquired aac(6′)−1b- cr, a gene known to confer low- level 
resistance to fluoroquinolones and aminoglycosides. Fluo-
roquinolone resistance gene qnrB4 was identified in isolates 
EC233_ST8196 and EC234_ST8196.
E. coli phylogroups and virulence gene profiling
Eighty- one genomes were screened against a panel of 65 
VAGs commonly found in pathogenic E. coli (Fig. 3, Files 
S3 and S4). The relative abundance of VAGs was highest in 
ST95 and ST73 isolates, followed by ST131 (Fig. 3, File. S4). 
In congruence with recent reports on co- relation between 
phylogroups and virulence gene profiles [51, 52], isolates 
belonging to Clermont phylogroups A, B1 and F carried fewer 
VAGs than the isolates in phylogroups B2 and D (File S4). 
The fimH, yeeT, fyuA, irp2, sitA and iss genes were identi-
fied in over 80 % of the isolates in our cohort (File S3). Only 
four isolates, EC104, EC2, EC230 and EC19 (all phylogroup 
B2), carried ibeA. Of the 2 iron acquisition genes, iucD and 
irp2, iucD was present in 52 isolates (8 phylogroup D and 1 
each of phylogroups A and D, with the rest B2), and 72 tested 
positive for irp2 (all 68 phylogroup B2 and 2 each of A and 
F). A previous single hospital study of E. coli from BSIs also 
highlighted an abundance of fimH, papC, iha and ibeA genes 
[53].
The distribution of the six ExPEC- specific protectins, namely 
kpsMT II, kpsMT III, traT, ompT, iss and cavC, and two toxins, 
hly and cnf1, was also determined. Forty isolates tested 
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Table 1. Resistance genes and plasmid profile of isolates sequenced and analysed in this study.
Isolate descriptor Resistance genes in the 
genome
Class 1 integron- 
associated genes
ESBL genes Fluoroquinolone resistance genes Plasmid replicons
EC70_ST131H * $ # aac-3- lla, aacA4, aadA5, 
dfrA17, sul1, TEM- 1B
aadA5, 
dfrA17,mph(A), sul1
CTX- M-15, OXA-1 gyrA(S83L, D87N);parC(S80I, 
E84V)
IncFII
EC137_ST2003C * $ # aac-3- Ib, aac(6')−1b- cr, 
aacA4,cmlA1, dfrA1, mph(A), 
sul1, tet(B), TEM- 1B





EC234_ST8196H * $ # qnrB4, aac-3- lla, aadA5, 




CTX- M-15 gyrA(S83L, D87N);parC(S80I, 
E84V),qnrB4
IncFII, IncI1, Col156, 
pColBS512
EC345_ST10C * # aadA1, catA1, tet(B) OXA1, aadA1 OXA-1 gyrA(S83L, D87N);parC(S80I, 
E84V)
IncFII
EC385_ST73C * aph-3- Ia, TEM- 1B, dfrA17, 
mph(A), strA/B, sul2, tet(B)
dfrA17 – gyrA(S83L) IncFII, IncFIB, 
Col156, pColBS512
EC308_ST131C * catA1, dfrA7, sul1, TEM- 1B catA1, dfrA7 – – IncFII, IncFIA, 
IncFIB, Col156
EC236_ST540C * # aph-3- la, dfrA5, sul1, sul2, 
strA/B tet(A), TEM- 1B
dfrA5 – – IncFII, IncFIB, 
pBS512,pSL483
EC247_ST69H * dfrA7, sul1, sul2, strA/B, 
tet(A), TEM- 1B
dfrA7 – – IncFII, IncFIA, 
IncFIB, pCol4401
EC275_ST131C * aac-3- lld,aadA5, dfrA17, 
mph(A), sul1, sul2, strA/B, 
tet(A), TEM- 1B
aadA5, dfrA17,sul1,mph(A) gyrA(S83L) IncFII, IncFIB, 
Col156




CTX- M-14 – IncFII, IncFIB, 
IncFIA, 
Col156,pColBS512









EC357_ST131C * $ # aac-3- IIb, aacA4, dfrA14, 
strA/B, sul2, tet(A), TEM- 1B
dfrA14 CTX- M-15, OXA-1 gyrA(S83L, D87N);parC(S80I, 
E84V)
IncFII, IncFIB





CTX- M-27 – IncFII, IncFIB
EC46_ST131H * $ # aac-3- lla, aac(6')−1b- cr, 
aadA5, dfrA17, mph(A), sul1, 









EC36_ST38H * $ # aac-3- lld, aadA5, dfrA17, 





CTX- M-15 gyrA(S83L, D87N);parC(S80I) IncFII, IncFIB, IncI1, 
Col156
EC169_ST73C * # aadA1, sul1, TEM- 1B aadA1,sul1 – – IncFII, IncFIB, 
Col156




– gyrA(S83L, D87N);parC(S80I, 
E84V)
IncFII, IncFIA, IncI1, 
Col156
EC222_ST73H * aadA1, sul1, TEM- 1B aadA1 – IncFII, IncFIB, 
Col156
EC182_ST73C * aadA1, dfrA1, sul1, strA/B, 
sul2, TEM- 1B
aadA1, dfrA1 – – IncFII, IncFIB, 
IncFIA
EC149_ST73C * aadA1, dfrA14,strA/
B,sul2,sul1, TEM- 1B
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Isolate descriptor Resistance genes in the 
genome
Class 1 integron- 
associated genes
ESBL genes Fluoroquinolone resistance genes Plasmid replicons
EC8_ST131C * aadA5, dfrA17, mph(A), sul1, 
TEM- 1B
aadA5, dfrA17 – IncFII, IncFIB, 
IncFIA, IncX4, 
Col156
EC233_ST8196C * $ # qnrB4, aac-3- lla, aadA5, 




CTX- M-15 gyrA(S83L, D87N);parC(S80I, 
E84V), qnrB4
IncFII, IncI1, Col156, 
pColBS512
EC120_ST131C * $ # aac-3- Ib, aacA4, dfrA14, 
strA/B, sul2, TEM- 1B





EC44_ST131H * $ # aac-3- lla, aac(6')−1b- cr, 
aadA5, dfrA17, mph(A), sul1, 




CTX- M-15, OXA-1 gyrA(S83L, D87N);parC(S80I, 






















EC164_ST73C * TEM- 1B – – – 0
EC226_ST349C * – – – – 0
EC285_ST648C * # – – – gyrA(S83L, D87N);parC(S80I) 0
EC274_ST38H * # aac-3- lld, catA1, tet(B), 
TEM- 1B
– – gyrA(S83L, D87N);parC(S80I, 
E84G)
IncFII, IncFIB
EC282_ST73C * TEM- 1B – – – IncFII




EC168_ST73C * TEM- 1B – – – IncFII, IncFIB, IncX4, 
Col156
EC25_ST88H * aadA1, dfrA1, sul1, TEM- 1B aadA1, dfrA1 – 0
EC393_ST131C * # TEM- 1B – – gyrA(S83L) 0
EC302_ST349C dfrA17, sul1, sul2, strA/B, 
tet(A), TEM- 1B
dfrA17 – IncFII, IncQ
EC272_ST73C aadA1, sul1, TEM- 1B aadA1 – – IncFII, IncFIB, 
Col156
EC347_ST73C aadA1, sul1 aadA1 SHV-48 – IncFII, IncFIB, 
Col156
EC337_ST69H dfrA5, TEM- 1B dfrA5 – IncB, IncFIB
EC323_ST549H dfrA5, TEM- 1B dfrA5 – – IncFII, IncFIB
EC330_ST681C dfrA5, sul1, strA/B, sul2, 
tet(A), TEM- 1B
dfrA5 – – IncB, ColBS512
EC290_ST127C dfrA5, sul1, TEM- 1B dfrA5 – – IncFIB, Col156
EC273_ST1434C aph-3- la, dfrA5, sul2, strA/B 
tet(A), TEM- 1B
dfrA5 – – IncFII, IncFIB, 
IncHI1, IncX4
EC131_ST131C aadA5, dfrA17, mph(A), sul1, 
strA/B, sul2, tet(A)
aadA5, dfrA17 – gyrA(S83L) IncFII, IncFIB, 
Col156
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Isolate descriptor Resistance genes in the 
genome
Class 1 integron- 
associated genes
ESBL genes Fluoroquinolone resistance genes Plasmid replicons
EC147_ST73C aadA1,dfrA1, strA/B, sul1, 
sul2, TEM- 1B
aadA1, dfrA1 – – IncFII, IncFIB, IncI1, 
Col156
EC65_ST127C aadA1, sul1, TEM- 1B aadA1 – IncFII, IncFIB, 
Col156
EC173_ST12C aadA1, dfrA1, sul1, tet(B), 
TEM- 1B
aadA1, dfrA1 – – IncFIA, IncFIB, 
Col156, ColVC
EC108_95C aadA2, catA1, dfrA12, 
mph(A), sul1, tet(B), TEM- 1B
dfrA12, aadA2 – – IncFII, IncFIB, 
IncFIA, Col156
EC16_ST1193C # dfrA17, strA/B, sul2, tet(B), 
TEM- 1B
dfrA17 gyrA(S83L, D87N);parC(S80I) IncFII, IncFIB, 
IncFIA, IncQ, Col156
EC5_ST73C aadA1, sul1, TEM- 1B aadA1 – – IncFII, IncFIB, 
Col156
EC152_ST95C aadA1, aadA2, cmlA1, 
dfrA12, sul3
aadA1, orfF, aadA2, 
cmlA1, dfrA12, sul3
– – IncFII, IncFIB
EC177_ST95H dfrA5 dfrA5 – – IncFII, IncFIB, 
Col156
EC45_ST57C aadA1, dfrA5, sul1, sul2, 
tet(C)
aadA1, dfrA5 – – IncFII, IncFIB
EC84_ST131H dfrA14, mphA dfrA14 – IncFII, IncFIB, 
Col156
EC56_ST164C – – – – 0
EC2_ST95C – – – – IncFIA, IncFIB, 
Col156
EC160_ST73C – – – – IncFII, IncFIB, 
Col156
EC178_ST69C TEM- 1B – – gyrA(S83L) IncFII, IncFIB, 
IncFIA
EC250_ST127C – – – – 0
EC235_ST117C – – – – IncFIB
EC230_ST91C – – – – IncFII, IncFIB
EC280_ST144C TEM- 1B – OXA-4 – IncFII, IncFIB, 
Col156
EC232_ST73C – – – – 0
EC249a_ST127H – – – – IncFII, IncFIB
EC276_ST906C – – – – IncFII, IncFIB
EC33_ST73C TEM- 1B, sul2 – – – 0
EC7_ST144C dfrA14, sul2, strA/B, TEM- 1B – – – IncB, IncFII, IncFIB, 
Col156
EC11_ST95C TEM- 1B – – – IncFII, IncFIB
EC51_ST69C sul1, TEM- 1B – – – IncB, IncFII, IncFIB, 
Col156
EC128_ST8197H TEM- 1C – – – IncFII, IncFIB, IncB, 
Col156
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Isolate descriptor Resistance genes in the 
genome
Class 1 integron- 
associated genes
ESBL genes Fluoroquinolone resistance genes Plasmid replicons
EC19_ST372C – – – – 0
EC35_ST69H – – – – IncB, IncFII, IncFIB, 
Col156
EC68_ST95C tet(B) – – – IncFIA, IncFII, 
IncFIB
EC20_ST73C – – – – 0
EC372_ST95C – – – – IncFIA, IncFIB, 
Col156
EC104_ST95C strA, strB, tet(B) – – gyrA(S83L) IncFII, IncFIB
EC123_ST88C strA, strB, sul2 – – – IncFII, IncFIB, IncQ
EC24_ST73C – – – 0
EC223_ST62C aadA1, dfrA1, tet(A) – gyrA(S83L) IncFIB, Col156
The isolate descriptor column consists of isolate number, the sequence type (ST) and hospital onset (H) or community onset (C) included as 
suffix, followed by symbols to include phenotypic profile, where MDR is indicated as *, ESBL producers are indicated as $ and fluoroquinolone 
-resistant isolates indicated as #.
Table 1. Continued
positive for kpsMT II, while only isolate EC323 tested positive 
for kpsMT III. Fourteen isolates were positive for ompT, 58 for 
traT, 67 for iss and 11 for cavC (File S3). None of the isolates 
tested positive for hlyA, but 22 (all phylogroup B2) were posi-
tive for cnf1. No obvious trend was observed in the relative 
distribution of genes encoding known outer- membrane iron 
receptors, such as fyuA, ireA, iroN and iutA, amongst the 
different E. coli sequence types, phylogroups (File S4) or CO 
vs HO infections.
Plasmid replicon diversity within the cohort
Plasmid typing identified IncFII and IncFIB replicons in most 
isolates (51/81), including 39 CO BSI and 12 HO BSI isolates 
(Table 1). In 11 isolates from CO infections and 3 from HO 
infections, FIA replicons were co- resident with IncFII and 
IncFIB replicons. We also identified small col- like plasmid 
replicons in 33 of the 51 isolates that carried IncFII and 
IncFIB replicons, raising the possibility of presence of large 
IncFII–IncFIB hybrid ColV- like virulence plasmids in them.
Two completely closed IncFII–IncFIB hybrid ColV- like 
plasmids, pCERC4 (Fig. S1a) and pSDJ2009- 52F (Fig. S1b), 
have recently been reported and characterized [54, 55] from 
Sydney. Illumina read mapping of all 81 genomes against both 
plasmids identified 12 isolates which appeared to carry most 
of the virulence and colicin resistance genes characteristic of 
ColV hybrid virulence plasmids (Fig. S1a, b). To examine this 
further, a series of blastn analyses of the ColV operon, col- Ia 
genes, the virulence gene repertoire and their linkage to repA 
and repA1 genes found on pCREC4 was conducted against all 
assembled genomes in our cohort. Combining data on scaf-
folds identified in our blastn analyses (File S5) and following 
the stringent parameters indicated in the Methods section, 
our assessment identified genetic features that define ColV- 
like IncFII–IncFIB plasmids in 10 isolates (Table 2). Of these, 
five typed as ST95 (EC104, EC68, EC177, EC152, EC11), two 
each as ST131 (EC120 and EC357) and ST88 (EC25, EC123), 
and one as ST540 (EC236). Two genomes (EC337 and EC323) 
that had the Col- V operon and col- Ia genes did not contain 
both (IncFII and IncFIB) replicons characteristic of hybrid 
IncFII–IncFIB plasmids and likely represent isolates with 
novel ColV- like IncF plasmid variants. All 10 isolates identi-
fied in the analysis as candidates likely hosting IncFII–IncFIB 
ColV- like plasmids did not return positive hits for both ColV 
operon and col- Ia genes (Table 2), indicating subtle variations 
in the structure of plasmids in this group. Further studies with 
completely closed plasmid sequences are required to char-
acterize them and examine the distribution of all ColV- like 
plasmid variants within isolates from the clinic and elsewhere.
We also identified an IncI1 replicon in six isolates (four asso-
ciated with HO and two with CO infections), four of which 
had an ISEcp1 associated with blaCTX- M-15 (Table 1) gene. An 
IncX4 replicon was identified in five isolates, three of which 
were ST131. Finally, an IncQ replicon was identified in three 
MDR isolates belonging to ST38, ST349 and ST88.
DISCuSSIon
This study and others show that BSIs are caused by genetically 
diverse E. coli [56], indicating that pathogen virulence profiles 
and perhaps host immune status are likely to be important 
variables in disease causation. E. coli ST131, often isolated 
from patients with BSI, is widely disseminated in Europe, 
Asia, North America, Africa and Australia [32, 57], and 
has played a critical role in the global spread of blaCTX- M-15 
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Fig. 3. A presence/absence heatmap of E. coli virulence genes. The phylogenetic relationship of the isolates is presented as a cladogram 
along the y- axis and the virulence genes are listed in the top panel along the x- axis. Grey boxes indicate the presence and black boxes 
indicate the absence of a gene. Virulence gene profiling was not performed for the two reference genomes (EC958 and E. coli K12), hence 
the corresponding rows are left blank.
[58]. Our data show that blaCTX- M-15 in BSIs in Sydney is not 
restricted to ST131 but extends to E. coli ST8196, ST393 and 
ST38. Chromosomal blaCTX- M-15 in ST131 is usually associated 
with ISEcpI elements, but in EC44_ST131, EC46_ST131 and 
EC66_ST393, blaCTX- M-15 is not linked to ISEcpI, suggesting a 
different genetic context, including an association with other 
plasmids.
Although our data are based on a limited number of isolates 
acquired from a single hospital in Sydney, they highlight 
similar population dynamics in the context of resistance 
and virulence genes found in invasive isolates reported on 
a cohort of more than 1500 E. coli collected over 11 years in 
the UK [57]. The number of virulence genes carried by ST131 
was - less than that in the cohort of E. coli ST73 (Fig. 3, Files 
S3 and S4), suggesting that there is segregation between exces-
sively virulent and extremely drug- resistant clonal lineages 
[59]. However, acquisition of virulence plasmids such as ColV 
that carry CRLs may alter this scenario, necessitating constant 
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Table 2. Summary of the blastn analysis of genomes with col V operon, col- Ia genes and the repertoire of virulence genes and the repA gene present 
on pCERC-4 (accession no. KU578032).
Isolate identifier Sequence type pCREC-4 rep 
genes
Positive hits to pCERC-4 virulence gene (n=20)
Isolates with both colV operon and col- Iagenes
  EC337_ST69H 69 repA_FIB iroC,iutA,iroN,etsB,iucA,iucC,etsC,iucD,iroD,etsA,iroB,hlyF,iroE,ompT,iucB,sitA,sitD,sitC,sitB,iss
  EC25_ST88H* 88 repA_FIB, 
repA1_FII
iroC,iutA,iroN,etsA, etsB,etsC, iucA,iucC,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitA,sitD,sitC,sitB,iss
  EC104_ST95C* 95 repA_FIB, 
repA1_FII$
iroC,iutA,iroN,etsA, etsB,etsCiucA,iucC,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitC,sitB,sitA,sitD,iss
  EC68_ST95C* 95 repA_FIB, 
repA1_FII$
iroC,iutA,iroN,etsA, etsB,etsCiucA,iucC,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitC,sitD,sitB,sitA,iss
  EC177_ST95H* 95 repA_FIB, 
repA1_FII
iroC,iroN,etsA,etsB,etsC,iroD, iroB,hlyF,iroE,ompT,sitA,sitC,sitD,sitB,iss
  EC120_ST131C* 131 repA_FIB, 
repA1_FII$
iroC,iutA,iroN,etsA, etsB,etsC,iucA,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitC,sitB,iucC,sitA,sitD,iss
  EC236_ST540C* 540 repA_FIB, 
repA1_FII
iroC,iutA,iroN,etsB,iucA,iucC,etsC,iucD,iroD,etsA,iroB,hlyF,iroE,ompT,iucB,sitA,sitD,sitC,sitB,iss
  EC323_ST549H* 549 repA_FIB iroC,iutA,iroN,etsA, etsB,etsC,iucA,iucC,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitA,sitD,sitC,sitB,iss
Isolates with colV operon only
  EC123_ST88C* 88 repA_FIB, 
repA1_FII$
iroC,iutA,iroN,etsA, etsB,etsC,iucA,iucC,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitA,sitD,sitC,sitB,iss
  EC152_ST95C* 95 repA_FIB, 
repA1_FII$
iroC,iutA,iroN,etsA, etsB,etsC,iucA,iucC,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitC,sitB,sitD,sitA,iss
  EC11_ST95C* 95 repA_FIB, 
repA1_FII$
iroC,iutA,iroN,etsA, etsB,etsC,iucA,iucC,iucD,iroD,iroB,hlyF,iroE,ompT,iucB,sitC,sitB,sitA,sitD,iss
  EC357_ST131C* 131 repA_FIB, 
repA1_FII$
iroC,iutA,iroN,etsA, etsB,etsC,iucA,iucD,iroD,iroB,hlyF,iucC,iroE,ompT,iucB,sitC,sitB,sitA
Isolates with col- Iagenes only
  EC232_ST73C 73 None detected iroC,iutA,iroN,iucA,iucC,iucD,iroD,iroB,iroE,iucB,sitA,sitC,sitD,sitB,iss
  EC230_ST91C 91 repA_FIB$, 
repA1_FII$
sitA,sitC,sitD,sitB,iss
  EC12_ST131H 131 repA1_FII$ iutA,iucA,iucC,iucD,iucB,sitA,sitC,sitD,sitB,iss
Asterisk (*) on ‘isolate identifiers’ indicates linkage of repA with virulence genes on the same genomic scaffold (detailed in File S5). Virulence 
genes highlighted in bold fonts indicate genes that were assembled on a single scaffold with the repA gene, indicating linkage. A dollar ($) sign in 
the pCERC-4 rep gene column represents ≥95 % but not 100 % identity with the respective rep gene sequence.
surveillance to identify emerging resistance threats [52]. 
While lineages of ST73 with MDR genotypes are commonly 
described, drug- sensitive lineages and lineages devoid of 
plasmids in Australia are also documented [60].
IncFII and IncFIB plasmid replicons were abundant in geneti-
cally diverse isolates acquired from both CO and HO BSIs. 
Virulence gene profiling studies suggested that a subset of 
E. coli isolates with ST95, ST131 and others likely carry an 
IncFII–IncFIB plasmid. Plasmids that have the ColV operon 
associated with IncF transfer regions often harbour a combi-
nation of virulence genes linked to serious human and animal 
diseases [24, 54, 61–65]. Based on an animal model of UPEC 
disease, it was demonstrated that acquisition of ColV- like 
plasmid and associated virulence genes influence disease 
aetiology [66, 67]. In addition, the acquisition of a ColV- like 
plasmid by Salmonella enterica serovar Kentucky has been 
purported to be a key genetic event that transformed its ability 
to cause serious disease in poultry by conferring new coloni-
zation and fitness capabilities [24]. ColV plasmids are impli-
cated in invasive avian diseases, such as colibacillosis caused 
by avian pathogenic E. coli (APEC) in commercial poultry, 
and are considered to be a defining trait of the ExPEC sub- 
pathotype [13, 61]. These plasmids carry an extensive suite of 
VAGSs necessary for colonization and disease formation in 
diverse hosts, including humans. Gene products that mediate 
increased serum survival (iss), membrane vesicle formation 
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protein (encoded by hlyF gene), outer- membrane protease 
activity (encoded by ompT), aerobactin biosynthesis (iuc 
operon), temperature- sensitive haemagglutination (encoded 
by tsh) and various (sit, iroN and eit) iron acquisition systems 
[5, 55] are significant in this regard. Our blastn analysis 
with assembled genomes supported initial observations from 
mapping of raw Illumina reads against two hybrid IncFII–
IncFIB–ColV plasmids, indicating the presence of genes in the 
ColV operon in EC11_ST95, EC152_ST95C, EC123_ST88C 
and EC357_ST131C. Strains carrying the ColV operon and 
col- Ia genes included EC104_ST95C, EC177_ST95H, EC120_
ST131C, EC337_ST69H, EC236_ST540C and EC25_ST88H. 
Our data also indicate that there are variabilities in the IncF 
plasmids circulating in our BSI cohort [54] and some may 
carry different combinations of the colV operon, col- Ia genes 
and a repertoire of virulence genes- the three features that 
define typical hybrid ColV plasmids. Further studies using 
long- read sequencing methodologies are required to address 
the diversity of plasmids carrying ColV- like virulence gene 
cargo and examine their associations with antibiotic resist-
ance genes .
Forty- seven isolates in the bacteraemia cohort (58 %) carry 
a class 1 integron (Table 1). As expected, most of the intI1- 
positive isolates carried a larger number of antibiotic resist-
ance genes compared to isolates that did not have a class 1 
integron. Almost all E. coli with intI1 carried a minimum 
set of genes encoding resistance to streptomycin (aadA 
gene cassettes) and/or trimethoprim (dfrA gene cassettes), 
sulphonamide drugs (sul1, sul2 or sul3 genes) and ampi-
cillin (blaTEM-1). Most isolates (34/49; 73 %) that displayed 
phenotypic resistances to trimethoprim, used commonly as 
a first- line treatment option for uncomplicated UTIs, also had 
a sulphonamide resistance gene associated with the class 1 
integron in the CRL. The class 1 integron is inarguably one 
the most successful genetic elements responsible for the rapid 
evolution of multiple drug resistance, as it has captured a wide 
array of resistance gene cassettes [68] and dispersed within 
diverse animal and plant commensals and pathogensin every 
continent [69]. The structural boundaries that define class 
1 integrons continue to evolve, often mediated by insertion 
of other mobile genetic elements such as IS26 [70–74] that 
is well documented to mobilize diverse antibiotic resistance 
genes. Class 1 integrons are found on various plasmid back-
bones, including conjugative broad- host- range plasmids, and 
is widely considered to be a reliable proxy for identification 
of multiple drug- resistant genomes [16, 75].
The MDR isolates in this cohort exhibited little diversity 
in the carriage of cassette- associated genes. Most class 1 
integrons appeared to be variants of In2 or In4, some of 
which were associated with Tn21/Tn1721 hybrid transposon 
backbones. Our data identified IS26 adjacent to resistance 
genes in most of the CRLs (Fig. 3) and their presence creates 
scaffold breaks in the assembly of genome sequences. We 
also provide evidence for multiple IS26 elements per E. coli 
genome (Table  1), reinforcing the role played by IS26 in 
driving the evolution of multidrug resistant phenotypes in 
the Enterobacterales, including those causing BSIs. This is a 
critically important observation because: (i) IS26 can mobi-
lize a wide range of antibiotic resistance genes; (ii) IS26 is 
a preferred site for integration of translocatable units (TUs) 
; and (iii) CRLs flanked by IS26 have the capacity to move 
laterally as independent TUs [76]. These observations empha-
size the necessity for targeting mobile resistance scaffolds in 
developing and implementing comprehensive surveillance 
protocols for resistance gene epidemiology. Integration of 
such real- time surveillance data on the mobile resistome of 
pathogen and commensal populations in healthcare settings 
will better assist infection control teams to identify hotspots 
for the evolution of MDR pathogens.
One of the most significant findings from this study is the 
identification of ST8196 within the ST131 clonal complex. 
ST8196 isolates shared similar genotypic, phenotypic and 
plasmid profiles with ST131 isolates in the cohort. Both 
ST8196 isolates were identified from the 2014 sample pool 
and displayed resistance to multiple antibiotics, carriage of 
blaCTX- M-15 and chromosomal parC and gyrB mutations known 
to confer fluoroquinolone resistance (Table 1). In addition, 
the ST8196 isolates have acquired a plasmid- associated qnrB4 
gene. The isolation of ST8196 with plasmid- encoded qnrB4 
genes indicates that active surveillance for this ST is needed 
in Sydney and Australia more broadly.
In conclusion, MDR isolates in this genetically diverse BSI 
cohort exhibit limited variation in class 1 integron struc-
ture and in the cassette arrays they carry. IS26 is playing a 
significant role in shaping the composition of genes in the 
CRLs, which mostly include class 1 integrons in pathogenic 
E. coli. The role played by IS26 in the evolution of CRL is 
significant because they present furtheropportunities to 
rapidly acquire antibiotic resistance genes, including ones 
encoding resistance to clinically important antibiotics. We 
have identified E. coli in this cohort of isolates from BSIs 
that carry the plasmid- associated fluoroquinolone resistance 
gene qnrB4 and blaCTX- M-15. Dissemination of such plasmids 
may contribute to the rapid rise of co- resistance to two clini-
cally important groups of antibiotics. Finally, IncF plasmids 
are important in the evolution of resistance and virulence 
attributes in E. coli causing BSIs in Australia. A detailed 
investigation of the plasmids that circulate in E. coli causing 
bacteraemia is warranted.
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